Variant report
Variant | esv2390771 |
---|---|
Chromosome Location | chr1:246647210-246647685 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr1:246647202-246648395 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr1:246647613-246648442 | GM12878 | blood: | n/a | n/a |
3 | EBF1 | chr1:246647546-246647928 | GM12878 | blood: | n/a | n/a |
4 | FOXA1 | chr1:246647249-246647598 | HepG2 | liver: | n/a | n/a |
5 | IRF4 | chr1:246647182-246648490 | GM12878 | blood: | n/a | n/a |
6 | PAX5 | chr1:246647127-246648591 | GM12878 | blood: | n/a | n/a |
7 | RXRA | chr1:246647531-246648063 | GM12878 | blood: | n/a | n/a |
8 | SIX5 | chr1:246647193-246647710 | GM12878 | blood: | n/a | n/a |
9 | SP1 | chr1:246647474-246648654 | GM12878 | blood: | n/a | n/a |
10 | SP1 | chr1:246647381-246648061 | GM12878 | blood: | n/a | n/a |
11 | ZBTB33 | chr1:246647561-246647925 | K562 | blood: | n/a | n/a |
12 | ZBTB33 | chr1:246647333-246647947 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SMYD3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573693220 | chr1:246647235-246647236 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs73134187 | chr1:246647245-246647246 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs192026047 | chr1:246647268-246647269 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs150984658 | chr1:246647271-246647272 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs541250213 | chr1:246647301-246647302 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs111613115 | chr1:246647309-246647310 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs7540483 | chr1:246647323-246647324 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs111652174 | chr1:246647325-246647326 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs7540489 | chr1:246647328-246647329 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs564731021 | chr1:246647342-246647343 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs112237380 | chr1:246647348-246647349 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs7540559 | chr1:246647375-246647376 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs7547748 | chr1:246647380-246647381 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs80274110 | chr1:246647394-246647395 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs112792525 | chr1:246647400-246647401 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs78247246 | chr1:246647401-246647402 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs549878606 | chr1:246647412-246647413 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs111272761 | chr1:246647429-246647430 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs199728005 | chr1:246647432-246647433 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs529254624 | chr1:246647433-246647434 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs549015844 | chr1:246647451-246647452 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs7547243 | chr1:246647452-246647453 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs111470435 | chr1:246647458-246647459 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs55906553 | chr1:246647465-246647466 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs7549986 | chr1:246647481-246647482 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs534949953 | chr1:246647485-246647486 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs76313857 | chr1:246647504-246647505 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs571439572 | chr1:246647507-246647508 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs74163451 | chr1:246647516-246647517 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs35983452 | chr1:246647533-246647534 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs557101659 | chr1:246647535-246647536 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs573631643 | chr1:246647537-246647538 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs542641224 | chr1:246647550-246647551 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs552973385 | chr1:246647555-246647556 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs79757460 | chr1:246647556-246647557 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs33954186 | chr1:246647563-246647564 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs34490158 | chr1:246647583-246647584 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs34300324 | chr1:246647585-246647586 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs541732930 | chr1:246647587-246647588 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs564488566 | chr1:246647588-246647589 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs11806531 | chr1:246647589-246647590 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs7547364 | chr1:246647602-246647603 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs533582761 | chr1:246647606-246647607 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs61839822 | chr1:246647608-246647609 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs202188883 | chr1:246647632-246647633 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs377666818 | chr1:246647637-246647638 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs369468175 | chr1:246647640-246647641 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs76411171 | chr1:246647641-246647642 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs113527935 | chr1:246647654-246647655 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs143713327 | chr1:246647660-246647661 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Disease | 21936942 | CNVD |
laryngomalacia | 21936942 | CNVD |
GLUT3 deficiency syndrome | 20509907 | CNVD |
Developmental delay | 21373258 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Developmental delay | 19490664 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Cutaneous malignant melanoma | 18794153 | CNVD |
Astrocytoma | 17934521 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Breast cancer | 20409316 | CNVD |
Fibroblasts | 17951408 | CNVD |
Lung cancer | 17951408 | CNVD |
Schizophrenia | 20967226 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 19805367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:246623600-246663200 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr1:246644800-246648400 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr1:246646200-246647400 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
4 | chr1:246646600-246647400 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
5 | chr1:246647200-246647400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr1:246647200-246647400 | Enhancers | GM12878-XiMat | blood |
7 | chr1:246647400-246648400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |